About Medisun Lifescience
Medisun Lifescience is a Healthcare company based in Surat (India) founded in 2012. It operates as a manufacturing and exporting of pharmaceutical products, including tablets, capsules, and syrups, in India. Its Indian entity Medisun Lifescience Private Limited reported revenue of ₹3.59 Cr. Medisun Lifescience offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Formulations and Nutraceuticals and Wellness Products.
Company details
Medisun Lifescience Pvt. Ltd. is identified as a key manufacturer and exporter of pharmaceutical formulations and nutraceuticals, with products such as tablets, capsules, oral liquids, and injections being produced in Surat, Gujarat. Efforts are directed towards ensuring medicines are made available at affordable prices while upholding quality standards and fulfilling social responsibilities without discrimination. The company is recognized for extending support beyond business motives to alleviate human sufferings through accessible healthcare solutions.
- Headquarters Surat, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook Instagram
- Legal Name Medisun Lifescience Private Limited
- Date of Incorporation 08 May, 2012
- Jurisdiction Surat, Gujarat, India
- Annual Revenue₹3.59 Cr
FY 2024 · +2% YoY
- Net Profit₹3 Lakh
FY 2024 · 1% margin
- EBITDA₹4.9 Lakh
FY 2024 · 1% margin
Associated legal entities of Medisun Lifescience
Medisun Lifescience operates through Medisun Lifescience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medisun Lifescience Private Limited CIN U51909GJ2012PTC070243 | Active | 08 May 2012 | Surat, Gujarat | ₹3.6 Cr | – | 7 | View details |
Products & Services of Medisun Lifescience
Medisun Lifescience offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured and exported by Medisun Lifescience, including various types like chewable and bilayered tablets for pharmaceutical use
Capsules are produced and supplied by Medisun Lifescience for a range of applications in pharmaceuticals and nutraceuticals
Board of directors of Medisun Lifescience Private Limited (Medisun Lifescience)
Medisun Lifescience Private Limited is the primary company behind Medisun Lifescience. The board of Medisun Lifescience Private Limited currently have 7 directors; the longest-serving is Rajeshri Dharmendra Pipaliya, appointed in 2012. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajeshri Dharmendra Pipaliya DIN 05255195 | Director | 08 May 2012 | 14 yrs 5 mo | Medisun Lifescience Private Limited |
| Sonalben Pradipkumar Savaliya DIN 05283860 | Director | 25 May 2012 | 14 yrs 4 mo | Medisun Lifescience Private Limited |
| Amitaben Darshankumar Godhani DIN 05314497 | Director | 02 Jul 2012 | 14 yrs 3 mo | Medisun Lifescience Private Limited |
| Bhatrusha Bharatbhai Sonani DIN 05314503 | Director | 02 Jul 2012 | 14 yrs 3 mo | Medisun Lifescience Private Limited |
| Deepika Kalpeshbhai Lathiya DIN 06816286 | Director | 15 Feb 2014 | 12 yrs 8 mo | Medisun Lifescience Private Limited |
| Anishkumar Bharatbhai Patel DIN 11309102 | Director | 25 Sep 2025 | 1 yr | Medisun Lifescience Private Limited |
| Shaileshkumar Dhirubhai Parekh DIN 11309078 | Director | 25 Sep 2025 | 1 yr | Medisun Lifescience Private Limited |
Financials of Medisun Lifescience
Figures of Medisun Lifescience Private Limited, the primary company behind Medisun Lifescience, for FY 2024. Revenue was ₹3.59 Cr (+2% year on year). Net profit was ₹3 Lakh (1% margin). EBITDA was ₹4.9 Lakh (1% margin). Revenue has grown at a compounded annual rate of +15% over three years and +11% over five years.
- ₹3.59 CrRevenue · FY 2024 · +2% YoY
- ₹3 LakhNet profit · 1% margin
- ₹4.9 LakhEBITDA · 1% margin
- ₹17.5 LakhPaid-up capital
- +15%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medisun Lifescience Private Limited are on its company page.
Detailed financial statements for Medisun Lifescience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Medisun Lifescience (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medisun Lifescience
Medisun Lifescience was founded in 2012.
Medisun Lifescience is headquartered in Surat, India. It is registered at Surat, Gujarat, India.
The primary company behind Medisun Lifescience, Medisun Lifescience Private Limited, reported revenue of ₹3.59 Cr for FY 2024, up 2% year on year.
Medisun Lifescience Pvt. Ltd. is identified as a key manufacturer and exporter of pharmaceutical formulations and nutraceuticals, with products such as tablets, capsules, oral liquids, and injections being produced in Surat, Gujarat. Efforts are directed towards ensuring medicines are made available at affordable prices while upholding quality standards and fulfilling social responsibilities without discrimination. The company is recognized for extending support beyond business motives to alleviate human sufferings through accessible healthcare solutions.
Medisun Lifescience offers Tablets and Capsules.
Medisun Lifescience operates through Medisun Lifescience Private Limited.
The legal entities of Medisun Lifescience currently have 7 directors, including Deepika Kalpeshbhai Lathiya, Sonalben Pradipkumar Savaliya, Amitaben Darshankumar Godhani and others.